Sheldon Berger
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
-
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Thyroid Disorders and Treatments 2
- Diabetes Management and Research 2
- Surgery 7
- Pancreatic function and diabetes 6
- Co-authors
- Robert J. Metz (3 shared papers)Mary E. Mako (2 shared papers)Stephen P. Thomson (1 shared paper)Vivian Andrew Fonseca (1 shared paper)David S.H. Bell (1 shared paper)J. P. Raufman (1 shared paper)Robert E. Ratner (1 shared paper)Piero P. Foà (2 shared papers)
- Journals
- Diabetes (4 papers)Annals of the New York Academy of Sciences (2 papers)New England Journal of Medicine (2 papers)JAMA (1 paper)Science (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Sheldon Berger
22 papers receiving 373 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 202
- Pharmacology 72
- Physiology 71
- Surgery 116
- Pathology and Forensic Medicine 46
Countries citing papers authored by Sheldon Berger
This map shows the geographic impact of Sheldon Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Berger more than expected).
Fields of papers citing papers by Sheldon Berger
This network shows the impact of papers produced by Sheldon Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Berger. The network helps show where Sheldon Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1969 | 84 | |
| 2 | 1966 | 67 | |
| 3 | 2000 | 56 | |
| 4 | 2004 | 55 | |
| 5 | 2000 | 46 | |
| 6 | 1952 | 34 | |
| 7 | 1985 | 17 | |
| 8 | 1968 | 13 | |
| 9 | 1966 | 11 | |
| 10 | 1952 | 11 | |
| 11 | 1962 | 10 | |
| 12 | 1970 | 9 | |
| 13 | 1979 | 8 | |
| 14 | Preservation of insulin and liver glycogen stores during very long fasts. | 1968 | 6 |
| 15 | 1968 | 6 | |
| 16 | 1953 | 6 | |
| 17 | 1968 | 5 | |
| 18 | General pharmacology of S 15261, a new concept for treatment of diabetes. | 1998 | 5 |
| 19 | 1967 | 4 | |
| 20 | 1995 | 3 |
About Sheldon Berger
Sheldon Berger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Endocrine and Autonomic Systems, Cell Biology and Physiology, having authored 22 papers that have together received 461 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (6 papers), Muscle metabolism and nutrition (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Pharmacology and Obesity Treatment (2 papers), Thyroid Disorders and Treatments (2 papers), Regulation of Appetite and Obesity (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (202 citations), Pharmacology (72 citations), Physiology (71 citations), Surgery (116 citations) and Pathology and Forensic Medicine (46 citations). Sheldon Berger has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert J. Metz, Mary E. Mako, Stephen P. Thomson, Vivian Andrew Fonseca, David S.H. Bell, J. P. Raufman, Robert E. Ratner, Piero P. Foà, Lois Jovanovič and Vincent C. Woo. Their work appears in journals such as Diabetes, Annals of the New York Academy of Sciences, New England Journal of Medicine, JAMA and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.